| Healthcare and guidelines: A population-based survey of recorded medical problems and health surveillance for people with Down syndrome. | |
| | |
MedLine Citation:
|
PMID: 21501111 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background Medical problems are described in a population of persons with Down syndrome. Health surveillance is compared to the recommendations of national guidelines. Method Case records from the specialised and primary healthcare and disability services were analysed. Results A wide spectrum of age-specific medical and surgical problems was described. Congenital heart defects and middle ear infections were mostly experienced by younger people, while thyroid disease, epilepsy, and Alzheimer's disease were frequent among older people. Psychiatric disorders and behavioural problems were frequent in all age groups. Conclusions Health surveillance remained insufficient, despite the guidelines available. A joint effort by healthcare and disability service providers is required to ensure that the medical needs of people with Down syndrome are adequately met across their entire lifespan. An active provision of healthcare and monitoring for this vulnerable group is needed. |
| | |
Authors:
|
Tuomo Määttä; Joonas Määttä; Tuula Tervo-Määttä; Anja Taanila; Markus Kaski; Matti Iivanainen |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-19 |
Journal Detail:
|
Title: Journal of intellectual & developmental disability Volume: - ISSN: 1469-9532 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9610837 Medline TA: J Intellect Dev Disabil Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Service Centre of Kuusanmäki, , Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A 24-year controlled follow-up of patients with silent gallstones showed no long-term risk of sympto...
Next Document: Monoclonal antibodies against ?-amyloid (A?) for the treatment of Alzheimer's disease: the A? target...